Trial Profile
Therapeutic effects of atorvastatin on blood sugar, insulin resistance and inflammatory mediators in patients with diabetes type 2
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 01 Sep 2016
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 04 Oct 2012 New trial record
- 22 Sep 2012 Recruitment complete, according to the Iranian Registry of Clinical Trials